Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Ventinova Medical, Eindhoven, Netherlands | UNKNOWN |
| Timple SA, Rua Simao Álvares 356 Conj. 41,42 e 51 - Pinheiros, Sao Paulo (Brasilien) | UNKNOWN |
Not provided
Not provided
Not provided
Not provided
Patients with chronic obstructive pulmonary disease (COPD) have a significantly increased risk of postoperative pulmonary complications (PPC). Protective ventilation of the lungs could reduce the rate of PPC in patients with COPD. It has been suggested that flow controlled ventilation (FCV) may be less invasive and more protective to the lungs than conventional ventilation in patients with COPD.
The primary aim of this study is to determine a optimal individual ventilation setting for FCV in ten participants with COPD.
The estimated worldwide chronic obstructive pulmonary disease (COPD) mean prevalence is 13.1%. In 2015, 3.2 million people died from COPD worldwide, and estimates show that COPD will be the third leading cause of death in 2030. Patients with COPD are at high risk for postoperative pulmonary complications (PPC). It has been proposed that FCV might be less-invasive and more protective for the lungs than conventional ventilation in patients with COPD. The pathophysiology of COPD is multifactorial, with the collapse of the central airways having a major impact on the symptoms. Minimizing the expiratory flow could prevent this airway pathology, and thus be beneficial in the ventilation of patients with COPD.
In the operation theater participants will be ventilated with flow controlled ventilation (FCV). Arterial blood gas analysis and electrical impedance tomography (EIT) will be measured.
The aim of the study is to determine the best end-expiratory pressure and driving pressure (assessed after anesthesia induction based on compliance and EIT parameters).
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Best end-expiratory pressure | Best end-expiratory pressure (mbar), defined as the end-expiratory pressure associated with the best compliance, best tradeoff between alveolar collapse and hyper distension (EIT) | 1 hour after tracheal Intubation |
| Measure | Description | Time Frame |
|---|---|---|
| Best driving pressure | Best driving pressure (peek pressure - end-expiratory pressure in mbar) associated with the best compliance, best tradeoff between alveolar collapse and hyper distension (EIT) | 1 hour after tracheal intubation |
| Dissipated energy |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Patients with verified COPD, scheduled for operations in general anesthesia, who present in the preassessment clinic of the University Medical Center Hamburg-Eppendorf during the study recruitment period, will be screened for eligibility.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| André Dankert, MD | Universitätsklinikum Hamburg-Eppendorf | Principal Investigator |
| Martin Petzoldt, MD | Universitätsklinikum Hamburg-Eppendorf | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University Medical Center Hamburg-Eppendorf | Hamburg | 20246 | Germany |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 31000678 | Background | Blanco I, Diego I, Bueno P, Casas-Maldonado F, Miravitlles M. Geographic distribution of COPD prevalence in the world displayed by Geographic Information System maps. Eur Respir J. 2019 Jul 18;54(1):1900610. doi: 10.1183/13993003.00610-2019. Print 2019 Jul. No abstract available. | |
| 28822787 | Background | GBD 2015 Chronic Respiratory Disease Collaborators. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Respir Med. 2017 Sep;5(9):691-706. doi: 10.1016/S2213-2600(17)30293-X. Epub 2017 Aug 16. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D029424 | Pulmonary Disease, Chronic Obstructive |
| ID | Term |
|---|---|
| D008173 | Lung Diseases, Obstructive |
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |
| D002908 | Chronic Disease |
Not provided
Not provided
Not provided
Not provided
Not provided
Calculated dissipated energy per liter of gas ventilated (J) during ventilation. |
| 1 hour after tracheal intubation |
| Required minute volume to maintain carbon dioxide partial pressure (pCO2) level | The minute volume (L/min) of the ventilator will be adjusted to maintain the preoperative baseline pCO2 level (blood gas analysis). | 1 hour after tracheal intubation |
| Applied mechanical power | Calculated applied mechanical power during ventilation (J/min) | 1 hour after tracheal intubation |
| Ventilation distribution | Expressed as the percentage of total pulmonary ventilation through each of the regions-of-interest, total 100%. | 1 hour after tracheal intubation |
| Delta Z | Measured variation of impedance (arbitrary units) by electrical impedance tomography. | 1 hour after tracheal intubation |
| Delta end-expiratory lung impedance | Variation of impedance plethysmography at end-expiration measured by electrical impedance tomography. | 1 hour after tracheal intubation |
| Distribution of regional tidal ventilation | Distribution of regional tidal ventilation will be determined as the relation of regional ΔZ/total ΔZ (expressed in percentage), measured by electrical impedance tomography. | 1 hour after tracheal intubation |
| Regional lung compliance | Calculated by electrical impedance tomography (ml/cm H2O) | 1 hour after tracheal intubation |
| Center of Ventilation | Variations of the pulmonary ventilation distribution in the ventral-dorsal and left-right direction measured by electrical impedance tomography. | 1 hour after tracheal intubation |
| Global inhomogeneity index | Impedance variations of each pixel between the end of inspiration and expiration measured by electrical impedance tomography. | 1 hour after tracheal intubation |
| arterial oxygen partial pressure (paO2) | Measured by blood gas analysis (mmHg) | 1 hour after tracheal intubation |
| carbon dioxide partial pressure (pCO2) | Measured by blood gas analysis (mmHg) | 1 hour after tracheal intubation |
| Horovitz quotient | Ratio of PaO2 (mmHg) and the fraction of oxygen of the inhaled air (FiO2). | 1 hour after tracheal intubation |
| Base excess | Measured by blood gas analysis (mmol/l) | 1 hour after tracheal intubation |
| potential of hydrogen (pH) | Measured by blood gas analysis | 1 hour after tracheal intubation |
| Resistance | Pressure change per flow change measured by the ventilator (kPa*s/l). | 1 hour after tracheal intubation |
| tidal volume | Measure by ventilator (ml) | 1 hour after tracheal intubation |
| Peak inspiratory pressure | Maximum pressure during the inspiration measured by the ventilator (mbar). | 1 hour after tracheal intubation |
| Respiratory rate | Measured by the ventilator (1/min) | 1 hour after tracheal intubation |
| End-tidal carbon dioxide (etCO2) | End-tidal carbon dioxide level measured by the ventilator (mmHg). | 1 hour after tracheal intubation |
| 17132052 | Background | Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006 Nov;3(11):e442. doi: 10.1371/journal.pmed.0030442. |
| 36730893 | Background | Dankert A, Neumann-Schirmbeck B, Dohrmann T, Greiwe G, Plumer L, Loser B, Sehner S, Zollner C, Petzoldt M. Preoperative Spirometry in Patients With Known or Suspected Chronic Obstructive Pulmonary Disease Undergoing Major Surgery: The Prospective Observational PREDICT Study. Anesth Analg. 2023 Oct 1;137(4):806-818. doi: 10.1213/ANE.0000000000006235. Epub 2022 Nov 1. |
| 33603356 | Background | Tsuboi N, Tsuboi K, Nosaka N, Nishimura N, Nakagawa S. The Ventilatory Strategy to Minimize Expiratory Flow Rate in Ventilated Patients with Chronic Obstructive Pulmonary Disease. Int J Chron Obstruct Pulmon Dis. 2021 Feb 12;16:301-304. doi: 10.2147/COPD.S296343. eCollection 2021. |
| 30396474 | Background | Barnes T, van Asseldonk D, Enk D. Minimisation of dissipated energy in the airways during mechanical ventilation by using constant inspiratory and expiratory flows - Flow-controlled ventilation (FCV). Med Hypotheses. 2018 Dec;121:167-176. doi: 10.1016/j.mehy.2018.09.038. Epub 2018 Sep 24. |
| 31351452 | Background | Bauer M, Opitz A, Filser J, Jansen H, Meffert RH, Germer CT, Roewer N, Muellenbach RM, Kredel M. Perioperative redistribution of regional ventilation and pulmonary function: a prospective observational study in two cohorts of patients at risk for postoperative pulmonary complications. BMC Anesthesiol. 2019 Jul 27;19(1):132. doi: 10.1186/s12871-019-0805-8. |
| 32086632 | Background | Borges JB, Cronin JN, Crockett DC, Hedenstierna G, Larsson A, Formenti F. Real-time effects of PEEP and tidal volume on regional ventilation and perfusion in experimental lung injury. Intensive Care Med Exp. 2020 Feb 21;8(1):10. doi: 10.1186/s40635-020-0298-2. |
| 34939921 | Background | Dankert A, Dohrmann T, Loser B, Zapf A, Zollner C, Petzoldt M. Pulmonary Function Tests for the Prediction of Postoperative Pulmonary Complications. Dtsch Arztebl Int. 2022 Feb 18;119(7):99-106. doi: 10.3238/arztebl.m2022.0074. |
| D020969 |
| Disease Attributes |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |